Scilex Holding Company announced a binding term sheet with Kazakhstan-based iHolding Group LLP for a $100 million investment, purchasing about 6.67 million shares at $15 each. This funding aims to support Scilex's strategic growth in healthcare, product development, acquisitions, and operations. The deal awaits due diligence, approvals, and regulatory clearance. The investment highlights growing international interest in Scilex's non-opioid pain management products and innovative therapies pipeline, aligning with iHolding's vision to develop Kazakhstan as a regional pharmaceutical hub.
First Bancorp announced a cash dividend of $0.24 per share on its common stock, payable on October 23, 2026, to shareholders of record as of September 30, 2026. The company reported solid financial performance, stable credit quality, and strong capit...
Amplitude's stock price has doubled from its year-to-date lows, driven by strong Q2 financial results and significant growth in enterprise customers. The company's AI Analytics platform benefits from faster application development cycles, resulting i...
Bandwidth Inc. is extending its collaboration with Salesforce by becoming the first certified carrier to support the global rollout of Salesforce's native Contact Center. Initially available in Europe, the U.K., Australia, and New Zealand, this expan...
Nexera Energy is finalizing its audited financials to lift a cease trade order and has secured partial revocation to raise $320,000 through a private placement. The company is restructuring its balance sheet by converting debt into equity, aiming to ...
Arthur J. Gallagher & Co. has acquired McMillan Insurance & Bonding Inc., operating as Innovise Business Consultants, a Colorado-based firm specializing in commercial insurance and surety bonding for industries like construction and energy. The Innov...
